CYP2C19 polymorphism has no influence on rabeprazole-based hybrid therapy for Helicobacter pylori eradication

AIM: To evaluate the impact of cytochrome P450 2C19 (CYP2C19) and interleukin-1β (IL-1β) polymorphisms on the efficacy of Helicobacter pylori (H. pylori) eradication by using rabeprazole-based hybrid therapy. METHODS: A total of 88 H. pylori-infected patients were recruited to receive 14-d of hybrid...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Tsung-Jung, Lee, Hsi-Chang, Lin, Chih-Lin, Wang, Chung-Kwe, Chen, Kuan-Yang, Wu, Deng-Chyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212610/
https://www.ncbi.nlm.nih.gov/pubmed/30397607
http://dx.doi.org/10.12998/wjcc.v6.i12.514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212610/
https://www.ncbi.nlm.nih.gov/pubmed/30397607
http://dx.doi.org/10.12998/wjcc.v6.i12.514

Ejemplares similares